CHEMUNG FINANCIAL CORP Q2 Earnings Summary
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 18 2025
0mins
Source: NASDAQ.COM
Earnings Performance: Chemung Financial Corp reported a loss of $6.45 million in Q2, compared to a profit of $4.99 million in the same period last year, with an EPS of -$1.35 versus $1.05 previously.
Analyst Expectations: Analysts had projected an earnings per share (EPS) of $0.39 for the quarter.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
Analyst Views on CHMG
Wall Street analysts forecast CHMG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CHMG is 60.00 USD with a low forecast of 60.00 USD and a high forecast of 60.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
0 Buy
1 Hold
0 Sell
Hold
Current: 58.430
Low
60.00
Averages
60.00
High
60.00
Current: 58.430
Low
60.00
Averages
60.00
High
60.00
About CHMG
Chemung Financial Corporation is a financial holding company. The Company through the Chemung Canal Trust Company (Bank) and CFS Group, Inc (CFS), provides a range of financial services, including demand, savings and time deposits, commercial, residential, and consumer loans, interest rate swaps, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services. The Company primarily focuses on banking and wealth management services. Its core banking segment attracts deposits from the public and uses such funds to originate consumer, commercial, commercial real estate, and other loans. Wealth management services provided by the Bank include services as executor and trustee under wills and agreements, and guardian, custodian, trustee, and agent for pension, profit-sharing and other employee benefit trusts, as well as various investment, pension, estate planning, and employee benefit administrative services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Chemung Financial Reports Strong Q4 Earnings
- Earnings Performance: Chemung Financial's Q4 GAAP EPS of $1.61 aligns with market expectations, demonstrating the company's ongoing commitment to maintaining stable profitability.
- Significant Revenue Growth: The company reported revenue of $30.51 million, a 17.9% year-over-year increase, exceeding market expectations by $1.03 million, indicating strong business momentum, particularly in lending and deposit services.
- Positive Market Reaction: The revenue beat may positively impact Chemung Financial's stock price, enhancing investor confidence in its future growth potential.
- Strong Financial Health: The continuous revenue growth and stable profitability suggest a solid financial position, providing a robust foundation for future investments and expansion.
Continue Reading
Chemung Financial Corporation Earnings Estimate Cut by 3.9%
- Earnings Estimate Cut: Chemung Financial Corporation's current year earnings estimate has been revised downward by 3.9% over the last 60 days, indicating potential profitability challenges that could negatively impact its stock performance.
- Industry Impact: Similarly, Archer-Daniels-Midland Company's earnings estimate has been cut by 4%, reflecting overall weakness in the agricultural commodities sector, which may lead to decreased investor confidence.
- Market Reaction: Cool Company Ltd. has seen a 6% downward revision in its earnings estimate, raising concerns about the liquefied natural gas transportation industry and potentially affecting its future financing capabilities.
- Investment Recommendations: Zacks Investment Research has highlighted five top stock picks, and despite inherent risks, stocks like Hims & Hers Health have previously surged by 209%, showcasing the diverse potential within the market.
Continue Reading